老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Aimmune Therapeutics, Inc.

34.49
0.0000
成交量：- -
成交额：- -
市值：22.68亿
市盈率：-7.68
高：34.49
开：34.49
低：34.49
收：34.49
52周最高：37.00
52周最低：10.09
股本：6,576.68万
流通股本：4,320.00万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-4.4923
每股收益(LYR):-3.9723
净资产收益率：-149.17%
总资产收益率：-53.24%
市净率：12.61
市盈率(LYR):-8.68

数据加载中...

总览公司新闻资讯公告
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/19

重要事件披露

8-K - Current report
2020/10/13

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

私有化交易

SC 13E3/A [Amend] - Going private transaction by certain issuers
2020/10/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/13

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/10/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/05

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/29

私有化交易

SC 13E3/A [Amend] - Going private transaction by certain issuers
2020/09/21

私有化交易

SC 13E3/A [Amend] - Going private transaction by certain issuers
2020/09/14

私有化交易

SC 13E3 - Going private transaction by certain issuers
2020/08/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/31

重要事件披露

8-K - Current report
2020/07/31

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/30

重要事件披露

8-K - Current report
更多